What’s next for Scott Gottlieb?

Tomorrow is Scott Gottlieb’s last day as commissioner of the FDA, meaning he will have issued his last press release, explained his last draft guidance, and sent his last scolding tweet about leftovers. He’s taking his skeletal socks back to Connecticut where, according to Gottlieb, he plans to spend the coming months with his family.

We certainly haven’t heard the last of him, but his next move remains unknown. Gottlieb’s past involves time as a venture capitalist, a stint with a think tank, and years as a consultant. Some of his forebears have taken roles in the drug industry, like Andrew von Eschenbach, while others, like Margaret Hamburg, have leaned toward public health. Robert Califf, his immediate predecessor, has done both.

Where do you think Gottlieb will end up?

Consulting
Venture capital
A nonprofit devoted to one of his pet issues
Boards of pharma companies

(It was tempting to include “head of regulatory affairs for Juul” as an option, but the prospect of again getting dragged by Gottlieb on Twitterproved to be a deterrent. You win, Scott.)